Toggle navigation
Home
Search
Services
Blog
Contact
About
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W.
Covance Laboratories, Inc., Vienna, VA, United States
Search 19 grants from Daniel Dalgard
Search grants from Covance Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Regulatory Mechanisms of GLUT4 Exocytosis
Hypoxia Adapatation and Fungal Virulence of Aspergillus fumigatus
Binaural Hearing with Bilateral Cochlear Implants: Binaural-Unmasking Advantages
Regulation of mRNA Turnover in Trypanosomes
Regulation of Macrophage Phenotypes in Lung Repair
Recently added grants:
PEA15 in Development of Liver Cancer and Its Therapeutic Implication
Helicase regulation during homologous recombination
The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer
Development of a multi-omic clinical decision platform to guide personalized therapy
Characterizing and targeting intra-tumor heterogeneity in triple negative breast cancer chemoresistance and multi-organ metastasis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM025601-010
Application #
3609869
Study Section
Project Start
1981-11-01
Project End
1984-10-31
Budget Start
1986-09-15
Budget End
1984-10-31
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Covance Laboratories, Inc.
Department
Type
DUNS #
City
Vienna
State
VA
Country
United States
Zip Code
22182
Related projects
NIH 1986
N01 CM
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W. / Covance Laboratories, Inc.
NIH 1985
N01 CM
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W. / Covance Laboratories, Inc.
Comments
Be the first to comment on Daniel Dalgard's grant